59th Annual Meeting of the Japanese Society of Neurology

Session information

Oral Session

[O-37] Neuroimmunology (MS and NMO2)

Fri. May 25, 2018 9:45 AM - 11:15 AM Room 13 (Royton Sapporo / Crystal Room C (2F))

Chair: Izumi Kawachi(Department of Neurology, Brain Research Institute, Niigata University)Commentator: Marco Prinz(University Freiburg, Institute of Neuropathology, Germany)

Masaaki Niino1, Toshiyuki Fukazawa2, Jun-ichi Kira3, Tatsusada Okuno4, Masahiro Mori5, Nobuo Sanjo6, Takashi Ohashi7, Hikoaki Fukaura8, Juichi Fujimori9, Yuko Shimizu10, Nobuhiro Mifune11, Yusei Miyazaki1, Eri Takahashi1, Seiji Kikuchi1, Dawn Langdon12, Ralph Benedict13, Makoto Matsui14 (1.Department of Clinical Research, Hokkaido Medical Center, 2.Sapporo Neurology Hospital, 3.Department of Neurology, Kyushu University, 4.Department of Neurology, Osaka University Graduate School of Medicine, 5.Department of Neurology, Chiba University, 6.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, 7.Department of Neurology, Tokyo Women's Medical University Yachiyo Medical Center, 8.Department of Neurology, Saitama Medical Center, Saitama Medical University, 9.Department of Neurology, Tohoku Medical and Pharmaceutical University, 10.Department of Neurology, Tokyo Women's Medical University School of Medicine, 11.School of Management, Kochi University of Technology, 12.Department of Psychology, Royal Holloway University of London, 13.Department of Neurology, University at Buffalo, 14.Department of Neurology, Kanazawa Medical University)

Yoshiki Takai1, Ichiro Nakashia1,2, Toshiyuki Takahashi1,3, Tatsuro Misu1,4, Hiroshi Kuroda1, Syuhei Nishiyama1, Ryo Ogawa1, Kimihiko Kanoko1, Kazuo Fujihara1,5, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, 2.Department of Neurology, Tohoku Medical and Pharmaceutical University, 3.Department of Neurology, National Yonezawa Hospital, 4.Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, 5.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)